Columbia, Maryland, November 2, 2017 – WellDoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in panel discussions in the coming months at prominent diabetes and healthcare conferences. The list of events is as follows:
Diabetes Technology Society (Bethesda, MD)
November 2 – 4, 2017, Bethesda North Marriott & Conference Center, Bethesda, MD
WellDoc’s thought leaders will present two posters and participate in a panel discussion:
- Poster – “Measures Derived from Patient Generated Health Data Provide Insights on Glycemic Control Beyond A1C for People with Type 2 Diabetes,” November 3, 6:15 p.m. ET. WellDoc Medical Director Mansur E. Shomali, MD, CM, will present.
- Poster – “Technology-Enabled Diabetes Self-Management Education & Support,” November 2, 6:15 p.m. ET. WellDoc Vice President of Clinical Advocacy Malinda Peeples, RN, MS, CDE, will present.
- Panel Discussion – “How Social Media Can Promote Healthy Behavior,” November 2, 12:40 p.m. ET. Ms. Peeples will co-moderate.
International Conference on Diabetes and Its Complications
November 2 – 4, 2017, The Doubletree Baltimore-BWI Airport, Linthicum, MD
Ms. Peeples will present “Leveraging the Power of Digital Health for Diabetes Population Health Self-Management Education” on November 3, 4:40 p.m. ET.
NIH-IEEE Special Topics Conference on Healthcare Innovations and Point-of-Care Technologies
November 6 – 8, 2017, NIH Natcher Conference Center, Bethesda, MD
WellDoc Chief Strategy Officer Anand K. Iyer, PhD, MBA, will present “Validation, Standards and Security” on November 7, 2:00 p.m. ET.
DiabetesMine Innovation Summit
November 16, 2017, Stanford University of Medicine, Palo Alto, CA
Dr. Shomali will be giving a demonstration on BlueStar® on November 16, 4:15 p.m. PT.
Frontiers Health Conference 2017
November 16 – 17, 2017, AXICA, Berlin, Germany
Dr. Iyer will participate in the keynote and panel discussion entitled, “Software as a Drug: The Dawn of Digital Therapies,” on November 17, 2:15 p.m. CEST.
WellDoc® is the leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model, and our foundation is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes. Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0-point mean A1C reduction for adults living with type 2 diabetes who used BlueStar®. For more information, visit www.welldoc.com.